BIOSONDA S.A.
The company is recognized as a global leader in the production of mollusk hemocyanins. These proteins act as carriers for generating monoclonal and polyclonal antibodies to peptides and haptens and also serve as nonspecific protein-based adjuvants in experimental human and veterinary vaccines.
Research and Applications
Biosonda Corporation is a immunopharmaceutical company, focused in the research production and commercialization of hemocyanins, for the development of cancer vaccines, adjuvants and for the production of antibodies to haptens and peptides.